Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2014
06/12/2014US20140163231 Hepatitis C Virus Inhibitors
06/12/2014US20140163206 Haptens of aripiprazole
06/12/2014US20140163115 Migraine Treatments using the Bone Homeostasis Drug Cinacalcet
06/12/2014US20140163111 Porous biomolecule-containing metal-organic frameworks
06/12/2014US20140163109 Taste-masked ibupropen granules
06/12/2014US20140163108 Oral pharmaceutical dispersion compositions
06/12/2014US20140163106 Protection against skin diseases by aurin tricarboxylic acid and its derivatives
06/12/2014US20140163105 Topical preparation for pain relief
06/12/2014US20140163104 Uses of and methods of treatment with cystathionine
06/12/2014US20140163103 Solid Pharmaceutical Compositions Containing Pregabalin
06/12/2014US20140163102 Medical dressing for respiratory epithelial cells
06/12/2014US20140163100 Methods of Treating Multiple Sclerosis and Preserving and/or Increasing Myelin Content
06/12/2014US20140163098 Compositions and methods for reducing body fat
06/12/2014US20140163097 Animal supplements and food compositions containing soluble monensin composition, and methods and processes therefor
06/12/2014US20140163096 Methods and compositions for treating hiv-associated diarrhea
06/12/2014US20140163095 Use of eribulin in the treatment of breast cancer
06/12/2014US20140163093 METHODS FOR TREATING INFLAMATORY CONDITIONS AND STATES, AND CANCERS BY ANTAGONIZING NF-kB ACTIVATION
06/12/2014US20140163091 Methods useful in the prevention of hypoxic injury
06/12/2014US20140163088 Compounds, composition, methods, targets for cancer therapy
06/12/2014US20140163087 Combined inhibition of the vitamin d receptor and dna replication in the treatment of cancer
06/12/2014US20140163080 Compositions and Methods for Treatment of Glaucoma
06/12/2014US20140163078 Mycobacterial Disease Detection, Treatment, and Drug Discovery
06/12/2014US20140163074 Pharmaceutical composition for treating dermatological autoimmune diseases
06/12/2014US20140163072 Method, composition and kit for treating frequent headaches
06/12/2014US20140163071 Bioavailable compositions of amorphous piperidinyl compounds
06/12/2014US20140163070 Treatment for cerebral palsy impaired speech in children
06/12/2014US20140163068 Pharmaceutical Compositions for the Treatment of CFTR Mediated Diseases
06/12/2014US20140163066 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
06/12/2014US20140163065 Preparation and therapeutic applications of (2s, 3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
06/12/2014US20140163064 Method for Alleviating Symptoms of Urinary Incontinence
06/12/2014US20140163063 Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
06/12/2014US20140163062 Remedy for psychoneurotic diseases
06/12/2014US20140163060 Films and Drug Delivery Systems Made Therefrom
06/12/2014US20140163059 Treatment with opioid antagonists and mtor inhibitors
06/12/2014US20140163057 Implantable Polymeric Device for Sustained Release of Buprenorphine
06/12/2014US20140163054 Methods And Formulations For Modulating Lyn Kinase Activity And Treating Related Disorders
06/12/2014US20140163053 Use of Tetrahydropyrimidines
06/12/2014US20140163051 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocyclical Guanidine, For Cosmetology, Wound Healing, Focal Dystonia and Muscular Spasm- Related Clinical Pathologies
06/12/2014US20140163050 Use of 1H-quinazoline-2,4-diones
06/12/2014US20140163047 Composition of a ceramic matrix with a controlled release drug, a tablet obtained from the composition and methods for obtaining the composition and the tablet
06/12/2014US20140163045 Small Molecule Xanthine Oxidase Inhibitors and Methods of Use
06/12/2014US20140163044 Compound Chemical Medicine Acting on Respiratory Disease, Preparation Process and Use Thereof
06/12/2014US20140163043 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
06/12/2014US20140163041 Lysine demethylase inhibitors for myeloproliferative or lymphoproliferative diseases or disorders
06/12/2014US20140163040 Pharmaceutical dosage form for immediate release of an indolinone derivative
06/12/2014US20140163037 Screening methods for identifying specific staphylococcus aureus inhibitors
06/12/2014US20140163036 Carbamate/urea derivatives
06/12/2014US20140163033 Pyrrolotriazinone derivatives as p13k inhibitors
06/12/2014US20140163030 Stable ophthalmic formulations
06/12/2014US20140163025 Indanyloxydihydrobenzofuranylacetic acids
06/12/2014US20140163012 Pyrido-/azepino-benzofuran and pyrido-/azepino-benzothiophene mch-1 antagonists, methods of making, and use thereof
06/12/2014US20140163011 Modulators of atp-binding cassette transporters
06/12/2014US20140163004 Pyrido-[2,3-D] Pyrimidines and Their Use as Kinase Inhibitors
06/12/2014US20140162996 Novel modulators of development of adipocyte and cancer cells
06/12/2014US20140162995 Compositions Comprising Antibacterial Agent and Tazobactam
06/12/2014US20140162994 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias
06/12/2014US20140162993 Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists
06/12/2014US20140162991 Testosterone-anastrozole (t + a) combination implants in the neo-adjuvant, local and systemic therapy of newly diagnosed, previously untreated breast cancer
06/12/2014US20140162990 Finafloxacin suspension compositions
06/12/2014US20140162989 Multiple-component solid phases containing at least one active pharmaceutical ingredient
06/12/2014US20140162988 Solid Solution Compositions and Use in Chronic Inflammation
06/12/2014US20140162987 Solid Solution Compositions and Use in Severe Pain
06/12/2014US20140162986 Methods for treatment of thiol-containing compound deficient conditions
06/12/2014US20140162984 Phosphonoxy quinazoline derivatives and their pharmaceutical use
06/12/2014US20140162982 Topical compositions for use in the prevention and/or treatment of dermatitis
06/12/2014US20140162981 Substituted aryloxazoles and their use
06/12/2014US20140162978 Method for the prevention and treatment of sepsis
06/12/2014US20140162976 Compositions comprising hydroxytyrosol and chondroitin and use thereof for the treatment, co-treatment or prevention of inflammatory disorders
06/12/2014US20140162974 Methods for modulation of phosphorus and fgf23
06/12/2014US20140162973 Palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent
06/12/2014US20140162971 Bromodomain inhibitors
06/12/2014US20140162970 Treating Cardiac Arrhythmias, Heart Failure, Peripheral Artery Disease and Stroke With Cyclopentyl-Triazolo-Pyrimidine or Derivative Thereof
06/12/2014US20140162969 Microspheres for treatment of brain tumours
06/12/2014US20140162968 Method for screening of agent for treating or preventing obesity
06/12/2014US20140162965 Compositions for oral drug administration
06/12/2014US20140162964 Use in brain degenerative diseases
06/12/2014US20140162962 Novel lipids and compositions for intracellular delivery of biologically active compounds
06/12/2014US20140162958 Copolymer-1 Composition and Methods of Use
06/12/2014US20140162955 Antagonizing Heparin With Salicylamide Compounds And Histamine Blocking Agents
06/12/2014US20140162952 Erap1-derived peptide and use thereof
06/12/2014US20140162946 Formulations and methods for weight loss and body contouring
06/12/2014US20140162935 Compositions Comprising Enzyme-Cleavable Oxycodone Prodrug
06/12/2014US20140162934 Novel lipids and compositions for intracellular delivery of biologically active compounds
06/12/2014US20140162874 Pesticidal compositions and processes related thereto
06/12/2014US20140162287 Method for Prognosing Response to Cancer Therapy with 5, 10, 15, 20-Tetrakis (Carboxyphenyl) Porphine
06/12/2014US20140161915 Solubilization of cucurminoid compounds and products thereof
06/12/2014US20140161913 Method for Improving Eye Health
06/12/2014US20140161912 Compositions and methods for tissue regeneration
06/12/2014US20140161908 Chroman derivatives, medicaments and use in therapy
06/12/2014US20140161907 Compositions and methods for nutrition supplementation
06/12/2014US20140161906 Use of angiogenesis antagonists in conditions of abnormal venous proliferation
06/12/2014US20140161903 Compositions for the Treatment and Prevention of Eyelid Swelling
06/12/2014US20140161900 Compositions for Regenerating Defective or Absent Myocardium
06/12/2014US20140161898 Methods and Compositions for Treating Skin
06/12/2014US20140161897 Method for treating cancers, such as myeloma and breast cancer, with a combination of tbl-12 and velcade
06/12/2014US20140161896 Particles for the treatment of neurodegenerative diseases
06/12/2014US20140161894 Sirna silencing of genes expressed in cancer
06/12/2014US20140161891 Composition of pi3k inhibitor and use thereof
06/12/2014US20140161889 Transdermal formulation containing cox inhibitors
06/12/2014US20140161888 Formulations of 6-mercaptopurine
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 7860